ONCS - OncoSec Medical Incorporated

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development11,952.74814,741.69413,132.898
Selling General and Administrative9,495.65912,144.3588,108.244
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-21,448.407-26,886.052-21,241.142
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes-21,448.407-26,886.052-21,241.142
Interest Expense---
Income Before Tax-21,448.407-26,886.052-21,241.142
Income Tax Expense1.3912.4621.969
Minority Interest---
Net Income From Continuing Ops-21,449.798-26,888.514-21,243.111
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-21,449.798-26,888.514-21,243.111
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-21,449.798-26,888.514-21,243.111